Tolerance and efficacy of ganciclovir in the treatment of cytomegalovirus infections in immunosuppressed patients.
Ho
W G
WG
Department of Medicine, UCLA Medical Center, Los Angeles, CA 90024.
Winston
D J
DJ
Champlin
R E
RE
D000212:Acyclovir / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000097:blood / Q000627:therapeutic use; D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D003587:Cytomegalovirus / Q000187:drug effects; D003586:Cytomegalovirus Infections / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D015774:Ganciclovir; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000188:drug therapy / Q000209:etiology; D011658:Pulmonary Fibrosis / Q000188:drug therapy / Q000209:etiology
D000998:Antiviral Agents; D015774:Ganciclovir; D000212:Acyclovir